Garden Stage EBIT

The latest EBIT for GSIW is $-10M as of September 2025. That compares with $-2M in the prior-year period — down 412.3% year over year. That is below the Finance sector average of $300B. Investors often review this figure alongside Garden Stage's historical trend and sector peers before judging valuation or financial health.

Over the past year, GSIW's EBIT moved from $-2M to $-10M — a 412.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Garden Stage's operating scale or balance-sheet position.

Against Finance companies, GSIW currently prints $-10M for EBIT, while the sector average sits near $300B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Garden Stage's growth, margins, and balance sheet.

A EBIT figure of $-10M for GSIW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Finance average is about $300B. Explore the charts below for those layers of context.

After noting GSIW's EBIT ($-10M), review year-over-year change from $-2M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.